Glycemic Control and the Risk of Tuberculosis: A Cohort Study

1. World Health Organization. Global strategy and targets for tuberculosis prevention, care and control after 2015. 2013 Nov 29 [cited 13 May 2015]. http://apps.who.int/gb/ebwha/pdf_files/EB134/B134_12-en.pdf?ua=1.

2. Jeon CY, Murray MB. Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med. 2008;5:e152. doi: 10.1371/journal.pmed.0050152 18630984

3. Baker MA, Harries AD, Jeon CY, Hart JE, Kapur A, Lonnroth K, et al. The impact of diabetes on tuberculosis treatment outcomes: a systematic review. BMC Med. 2011;9:81. doi: 10.1186/1741-7015-9-81 21722362

4. Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ, Paciorek CJ, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet. 2011;378:31–40. doi: 10.1016/S0140-6736(11)60679-X 21705069

5. Harries AD, Lin Y, Satyanarayana S, Lonnroth K, Li L, Wilson N, et al. The looming epidemic of diabetes-associated tuberculosis: learning lessons from HIV-associated tuberculosis. Int J Tuberc Lung Dis. 2011;15:1436–1444. doi: 10.5588/ijtld.11.0503 21902876

6. Leibovici L, Yehezkelli Y, Porter A, Regev A, Krauze I, Harell D. Influence of diabetes mellitus and glycaemic control on the characteristics and outcome of common infections. Diabet Med. 1996;13:457–463. doi: 10.1002/(sici)1096-9136(199605)13:5<457::aid-dia83>3.0.co;2-t 8737028

7. Dronge AS, Perkal MF, Kancir S, Concato J, Aslan M, Rosenthal RA. Long-term glycemic control and postoperative infectious complications. Arch Surg. 2006;141:375–380. doi: 10.1001/archsurg.141.4.375 16618895

8. Baker MA, Lin HH, Chang HY, Murray MB. The risk of tuberculosis disease among persons with diabetes mellitus: a prospective cohort study. Clin Infect Dis. 2012;54:818–825. doi: 10.1093/cid/cir939 22238171

9. Leung CC, Lam TH, Chan WM, Yew WW, Ho KS, Leung GM, et al. Diabetic control and risk of tuberculosis: a cohort study. Am J Epidemiol. 2008;167:1486–1494. doi: 10.1093/aje/kwn075 18400769

10. Leegaard A, Riis A, Kornum JB, Prahl JB, Thomsen VO, Sorensen HT, et al. Diabetes, glycemic control, and risk of tuberculosis: a population-based case-control study. Diabetes Care. 2011;34:2530–2535. doi: 10.2337/dc11-0902 21972407

11. Pealing L, Wing K, Mathur R, Prieto-Merino D, Smeeth L, Moore DA. Risk of tuberculosis in patients with diabetes: population based cohort study using the UK Clinical Practice Research Datalink. BMC Med. 2015;13:135. doi: 10.1186/s12916-015-0381-9 26048371

12. Pan SC, Ku CC, Kao D, Ezzati M, Fang CT, Lin HH. Effect of diabetes on tuberculosis control in 13 countries with high tuberculosis: a modelling study. Lancet Diabetes Endocrinol. 2015;3:323–330. doi: 10.1016/S2213-8587(15)00042-X 25754415

13. American Diabetes Association. Standards of medical care in diabetes—2013. Diabetes Care. 2013;36(Suppl 1):S11–S66. doi: 10.2337/dc13-S011 23264422

14. American Diabetes Association. (6) Glycemic targets. Diabetes Care. 2015;38(Suppl):S33–S40. doi: 10.2337/dc15-S009 25537705

15. Young BA, Lin E, Von Korff M, Simon G, Ciechanowski P, Ludman EJ, et al. Diabetes complications severity index and risk of mortality, hospitalization, and healthcare utilization. Am J Manag Care. 2008;14:15–23. 18197741

16. Taiwan National Health Insurance Administration. [National health insurance in Taiwan 2014–2015 annual report.] 2014 [cited 5 May 2016]. http://www.nhi.gov.tw/Nhi_E-LibraryPubWeb/CustomPage/P_Detail.aspx?FType=8&CP_ID=129.

17. Chen CC, Chiang CY, Pan SC, Wang JY, Lin HH. Health system delay among patients with tuberculosis in Taiwan: 2003–2010. BMC Infect Dis. 2015;15:491. doi: 10.1186/s12879-015-1228-x 26527404

18. Hernan MA. The hazards of hazard ratios. Epidemiology. 2010;21:13–15. doi: 10.1097/EDE.0b013e3181c1ea43 20010207

19. Therneau TM, Crowson CS, Atkinson EJ. Adjusted survival curves. 2015 Jan [cited 5 May 2016]. https://cran.r-project.org/web/packages/survival/vignettes/adjcurve.pdf.

20. Wen CP, Cheng CW, Cheng TY, Tsai MK, Chiang PH, Tsai SP, et al. Trends in betel quid chewing behavior in Taiwan—exploring the relationship between betel quid chewing and smoking. Taiwan J Public Health. 2009;28:407–419.

21. Lonnroth K, Williams BG, Cegielski P, Dye C. A consistent log-linear relationship between tuberculosis incidence and body mass index. Int J Epidemiol. 2010;39:149–155. doi: 10.1093/ije/dyp308 19820104

22. Therneau TM, Grambsch PM. Modeling survival data: extending the Cox model. New York: Springer; 2000.

23. White IR, Royston P, Wood AM. Multiple imputation using chained equations: issues and guidance for practice. Stat Med. 2011;30:377–399. doi: 10.1002/sim.4067 21225900

24. Rubin DB. Multiple imputation for nonresponse in surveys. Hoboken (New Jersey): John Wiley & Sons; 2008.

25. Miettinen OS. Proportion of disease caused or prevented by a given exposure, trait or intervention. Am J Epidemiol. 1974;99:325–332. 4825599

26. Olmos P, Donoso J, Rojas N, Landeros P, Schurmann R, Retamal G, et al. [Tuberculosis and diabetes mellitus: a longitudinal-retrospective study in a teaching hospital]. Rev Med Chil. 1989;117:979–983. 2519480

27. Dooley KE, Chaisson RE. Tuberculosis and diabetes mellitus: convergence of two epidemics. Lancet Infect Dis. 2009;9:737–746. doi: 10.1016/S1473-3099(09)70282-8 19926034

28. Martinez N, Kornfeld H. Diabetes and immunity to tuberculosis. Eur J Immunol. 2014;44:617–626. doi: 10.1002/eji.201344301 24448841

29. MacRury SM, Gemmell CG, Paterson KR, MacCuish AC. Changes in phagocytic function with glycaemic control in diabetic patients. J Clin Pathol. 1989;42:1143–1147. 2584425

30. Bagdade JD, Stewart M, Walters E. Impaired granulocyte adherence. A reversible defect in host defense in patients with poorly controlled diabetes. Diabetes. 1978;27:677–681. 658613

31. Yamashiro S, Kawakami K, Uezu K, Kinjo T, Miyagi K, Nakamura K, et al. Lower expression of Th1-related cytokines and inducible nitric oxide synthase in mice with streptozotocin-induced diabetes mellitus infected with Mycobacterium tuberculosis. Clin Exp Immunol. 2005;139:57–64. doi: 10.1111/j.1365-2249.2005.02677.x 15606614

32. Gomez DI, Twahirwa M, Schlesinger LS, Restrepo BI. Reduced Mycobacterium tuberculosis association with monocytes from diabetes patients that have poor glucose control. Tuberculosis (Edinb). 2013;93:192–197. doi: 10.1016/j.tube.2012.10.003

33. Singhal A, Jie L, Kumar P, Hong GS, Leow MK, Paleja B, et al. Metformin as adjunct antituberculosis therapy. Sci Transl Med. 2014;6:263ra159. doi: 10.1126/scitranslmed.3009885 25411472

34. Davidson MB, Schriger DL, Peters AL, Lorber B. Relationship between fasting plasma glucose and glycosylated hemoglobin: potential for false-positive diagnoses of type 2 diabetes using new diagnostic criteria. JAMA. 1999;281:1203–1210. 10199430

35. Liang CC, Tsan KW, Ma SM, Chow SF, Wu CC. The relationship between fasting glucose and HbA1c among customers of health examination services. Formos J Endocrinol Metab. 2010;1:1–5.

36. Azizi-Soleiman F, Heidari-Beni M, Ambler G, Omar R, Amini M, Hosseini SM. Iranian risk model as a predictive tool for retinopathy in patients with type 2 diabetes. Can J Diabetes. 2015;39:358–363. doi: 10.1016/j.jcjd.2015.01.290 25837808

37. Kunst H, Khan KS. Age-related risk of hepatotoxicity in the treatment of latent tuberculosis infection: a systematic review. Int J Tuberc Lung Dis. 2010;14:1374–1381. 20937175

38. Restrepo BI, Schlesinger LS. Impact of diabetes on the natural history of tuberculosis. Diabetes Res Clin Pract. 2014;106:191–199. doi: 10.1016/j.diabres.2014.06.011 25082309

39. Yu NC, Su HY, Chiou ST, Yeh MC, Yeh SW, Tzeng MS, et al. Trends of ABC control 2006–2011: a national survey of diabetes health promotion institutes in Taiwan. Diabetes Res Clin Pract. 2013;99:112–119. doi: 10.1016/j.diabres.2012.11.018 23265923

40. Walker RJ, Smalls BL, Campbell JA, Strom Williams JL, Egede LE. Impact of social determinants of health on outcomes for type 2 diabetes: a systematic review. Endocrine. 2014;47:29–48. doi: 10.1007/s12020-014-0195-0 24532079

41. Lonnroth K, Castro KG, Chakaya JM, Chauhan LS, Floyd K, Glaziou P, et al. Tuberculosis control and elimination 2010–50: cure, care, and social development. Lancet. 2010;375:1814–1829. doi: 10.1016/S0140-6736(10)60483-7 20488524